BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27295423)

  • 1. Bos taurus ultralong CDR H3 antibodies.
    Vadnais ML; Smider VV
    Curr Opin Struct Biol; 2016 Jun; 38():62-7. PubMed ID: 27295423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenetic factors driving formation of ultralong VH CDR3 in Bos taurus antibodies.
    Deiss TC; Vadnais M; Wang F; Chen PL; Torkamani A; Mwangi W; Lefranc MP; Criscitiello MF; Smider VV
    Cell Mol Immunol; 2019 Jan; 16(1):53-64. PubMed ID: 29200193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Unusual Genetics and Biochemistry of Bovine Immunoglobulins.
    Stanfield RL; Haakenson J; Deiss TC; Criscitiello MF; Wilson IA; Smider VV
    Adv Immunol; 2018; 137():135-164. PubMed ID: 29455846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity in the Cow Ultralong CDR H3 Antibody Repertoire.
    Haakenson JK; Huang R; Smider VV
    Front Immunol; 2018; 9():1262. PubMed ID: 29915599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Broad Role for Cysteines in Bovine Antibody Diversity.
    Haakenson JK; Deiss TC; Warner GF; Mwangi W; Criscitiello MF; Smider VV
    Immunohorizons; 2019 Oct; 3(10):478-487. PubMed ID: 31619454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reshaping antibody diversity.
    Wang F; Ekiert DC; Ahmad I; Yu W; Zhang Y; Bazirgan O; Torkamani A; Raudsepp T; Mwangi W; Criscitiello MF; Wilson IA; Schultz PG; Smider VV
    Cell; 2013 Jun; 153(6):1379-93. PubMed ID: 23746848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Diversity of Ultralong CDRH3s in Seven Bovine Antibody Heavy Chains.
    Dong J; Finn JA; Larsen PA; Smith TPL; Crowe JE
    Front Immunol; 2019; 10():558. PubMed ID: 30967877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conservation and diversity in the ultralong third heavy-chain complementarity-determining region of bovine antibodies.
    Stanfield RL; Wilson IA; Smider VV
    Sci Immunol; 2016 Jul; 1(1):. PubMed ID: 27574710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDR-H3 diversity is not required for antigen recognition by synthetic antibodies.
    Persson H; Ye W; Wernimont A; Adams JJ; Koide A; Koide S; Lam R; Sidhu SS
    J Mol Biol; 2013 Feb; 425(4):803-11. PubMed ID: 23219464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline-Encoded Positional Cysteine Polymorphisms Enhance Diversity in Antibody Ultralong CDR H3 Regions.
    Jenkins GW; Safonova Y; Smider VV
    J Immunol; 2022 Dec; 209(11):2141-2148. PubMed ID: 36426974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures.
    Zemlin M; Klinger M; Link J; Zemlin C; Bauer K; Engler JA; Schroeder HW; Kirkham PM
    J Mol Biol; 2003 Dec; 334(4):733-49. PubMed ID: 14636599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine IgM antibodies with exceptionally long complementarity-determining region 3 of the heavy chain share unique structural properties conferring restricted VH + Vlambda pairings.
    Saini SS; Farrugia W; Ramsland PA; Kaushik AK
    Int Immunol; 2003 Jul; 15(7):845-53. PubMed ID: 12807823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of ultralong DH regions through genomic rearrangement.
    Smider BA; Smider VV
    BMC Immunol; 2020 Jun; 21(1):30. PubMed ID: 32487018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Despite extensive similarity in germline DH and JH sequence, the adult Rhesus macaque CDR-H3 repertoire differs from human.
    Link JM; Larson JE; Schroeder HW
    Mol Immunol; 2005 May; 42(8):943-55. PubMed ID: 15829286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The smallest functional antibody fragment: Ultralong CDR H3 antibody knob regions potently neutralize SARS-CoV-2.
    Huang R; Warner Jenkins G; Kim Y; Stanfield RL; Singh A; Martinez-Yamout M; Kroon GJ; Torres JL; Jackson AM; Kelley A; Shaabani N; Zeng B; Bacica M; Chen W; Warner C; Radoicic J; Joh J; Dinali Perera K; Sang H; Kim T; Yao J; Zhao F; Sok D; Burton DR; Allen J; Harriman W; Mwangi W; Chung D; Teijaro JR; Ward AB; Dyson HJ; Wright PE; Wilson IA; Chang KO; McGregor D; Smider VV
    Proc Natl Acad Sci U S A; 2023 Sep; 120(39):e2303455120. PubMed ID: 37722054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recirculating bone marrow B cells in C57BL/6 mice are more tolerant of highly hydrophobic and highly charged CDR-H3s than those in BALB/c mice.
    Khass M; Buckley K; Kapoor P; Schelonka RL; Watkins LS; Zhuang Y; Schroeder HW
    Eur J Immunol; 2013 Mar; 43(3):629-40. PubMed ID: 23225217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural classification of CDR-H3 revisited: a lesson in antibody modeling.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2008 Nov; 73(3):608-20. PubMed ID: 18473362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
    Almagro JC; Raghunathan G; Beil E; Janecki DJ; Chen Q; Dinh T; LaCombe A; Connor J; Ware M; Kim PH; Swanson RV; Fransson J
    J Mol Recognit; 2012 Mar; 25(3):125-35. PubMed ID: 22407976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting antibody complementarity determining region structures without classification.
    Choi Y; Deane CM
    Mol Biosyst; 2011 Dec; 7(12):3327-34. PubMed ID: 22011953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.